Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

1.2K
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
1.2K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.3K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.3K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

360
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
360
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

726
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
726
Regression Analysis01:11

Regression Analysis

7.3K
Regression analysis is a statistical tool that describes a mathematical relationship between a dependent variable and one or more independent variables.
In regression analysis, a regression equation is determined based on the line of best fit– a line that best fits the data points plotted in a graph. This line is also called the regression line. The algebraic equation for the regression line is called the regression equation. It is represented as:
7.3K
Residuals and Least-Squares Property01:11

Residuals and Least-Squares Property

7.2K
The vertical distance between the actual value of y and the estimated value of y. In other words, it measures the vertical distance between the actual data point and the predicted point on the line
If the observed data point lies above the line, the residual is positive, and the line underestimates the actual data value for y. If the observed data point lies below the line, the residual is negative, and the line overestimates the actual data value for y.
The process of fitting the best-fit...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histopathological diagnosis of cutaneous melanocytic lesions: blinded and nonblinded second opinions offer similar improvement in diagnostic accuracy.

Clinical and experimental dermatology·2022
Same author

Combining biomarkers by maximizing the true positive rate for a fixed false positive rate.

Biometrical journal. Biometrische Zeitschrift·2021
Same author

Adding Rigor to Biomarker Evaluations-EDRN Experience.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2020
Same author

Statistical inference for net benefit measures in biomarker validation studies.

Biometrics·2019
Same author

Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.

JAMA network open·2019
Same author

Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the <i>AJCC Cancer Staging Manual</i>.

JAMA network open·2018
Same journal

Inference on summaries of a model-agnostic longitudinal variable importance trajectory with application to suicide prevention.

The annals of applied statistics·2026
Same journal

A NOVEL BAYESIAN FRAMEWORK UNCOVERING BRAIN CONNECTIVITY-TO-SHAPE RELATIONSHIP IN PRECLINICAL ALZHEIMER'S DISEASE.

The annals of applied statistics·2026
Same journal

EVALUATING MULTIPLEX DIAGNOSTIC TEST USING PARTIALLY ORDERED BAYES CLASSIFIER.

The annals of applied statistics·2026
Same journal

BRIDGING THE GAP: ENHANCING THE GENERALIZABILITY OF EPIGENETIC CLOCKS THROUGH TRANSFER LEARNING.

The annals of applied statistics·2026
Same journal

TREATMENT EFFECT HETEROGENEITY AND IMPORTANCE MEASURES FOR MULTIVARIATE CONTINUOUS TREATMENTS.

The annals of applied statistics·2026
Same journal

FEDERATED LEARNING OF ROBUST INDIVIDUALIZED DECISION RULES WITH APPLICATION TO HETEROGENEOUS MULTIHOSPITAL SEPSIS POPULATION.

The annals of applied statistics·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

895

LOGISTIC REGRESSION ANALYSIS WITH STANDARDIZED MARKERS.

Ying Huang1, Margaret S Pepe, Ziding Feng

  • 1Fred Hutchinson Cancer Research Center Public Health Sciences 1100 Fairview Avenue N., Seattle, WA 98109 ; University of Washington, Department of Biostatistics, Seattle, WA, 98195.

The Annals of Applied Statistics
|November 9, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces a novel method for analyzing diagnostic biomarker data, integrating logistic regression and ROC curve analysis for consistent results. This approach enhances biomarker evaluation and risk modeling, particularly for combining data across studies.

Keywords:
ROC curveconstrained likelihoodempirical likelihoodlogistic regressionpredictiveness curve

More Related Videos

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

2.9K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Related Experiment Videos

Last Updated: May 6, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

895
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

2.9K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Area of Science:

  • Biostatistics
  • Medical Informatics
  • Diagnostic Biomarker Research

Background:

  • Traditional analysis of diagnostic biomarker studies often uses separate methods for risk modeling (logistic regression) and performance evaluation (ROC curves).
  • This separation can lead to inconsistencies between model-fitting and performance assessment.
  • Combining biomarker data from multiple sources presents challenges in maintaining consistent analysis.

Purpose of the Study:

  • To present a unified method for analyzing diagnostic biomarker data that simultaneously performs risk modeling and performance evaluation.
  • To standardize biomarkers relative to the non-diseased population for improved logistic regression and ROC analysis.
  • To address the challenge of combining biomarker datasets from diverse studies or platforms while accounting for similar ROC curves.

Main Methods:

  • A novel statistical method standardizing biomarkers relative to the non-diseased population prior to logistic regression.
  • Simultaneous integration of risk prediction and classification performance assessment (ROC curves).
  • Development of constrained maximum likelihood and empirical likelihood estimators, applicable to cohort and case-control designs.
  • Method validation through simulation studies and illustration with the Prostate Cancer Antigen 3 (PCA3) dataset.

Main Results:

  • The proposed method ensures consistency between logistic regression results and ROC curve performance assessments.
  • It facilitates familiar covariate adjustment for both risk models and ROC curves.
  • The method allows incorporation of ROC curve structure assumptions into the fitted risk model.
  • Demonstrated effectiveness in combining biomarker data from multiple sources with similar ROC curves, as shown with the PCA3 dataset for prostate cancer diagnosis.

Conclusions:

  • The presented unified approach offers a more consistent and comprehensive analysis of diagnostic biomarker data.
  • Standardizing biomarkers is a key step enabling simultaneous risk and performance evaluation.
  • This method is valuable for meta-analyses of biomarker studies and for handling data from multiple platforms or populations.